Latest news

22/12/2020

Krebsforscher erhält Leibniz-Preis

Prof. Jürgen Ruland, from TUM’s Rechts der Isar Hospital at the Partner Site of the German Consortium for Translational Cancer Research (DKTK), will receive the 2021 Gottfried Wilhelm Leibniz Prize.…

01/12/2020

Rhine-Main Cancer Retreat 2020

End of October 2020, the annual DKTK Retreat of the partner site Frankfurt/Mainz took place for the 6th time. Joining forces with the Frankfurt Cancer Institute (FCI) and the Mildred Scheel Career…

12/11/2020

Sharing algorithms instead of data

The new Joint Imaging Platform – JIP for short – is a flexible, decentralized analysis platform for medical images. The JIP was initially developed for the German Cancer Consortium (DKTK) sites. It is…

20/10/2020

Pancreatic cancer: Subtypes with different aggressiveness discovered

Tumors of the pancreas are particularly feared. They are usually discovered late and mortality is high. Until now, no targeted and personalized therapies exist. Scientists at the German Cancer…

20/10/2020

Max Planck-Humboldt Research Award 2020 presented in life sciences for the first time

Molecular biologist Roberto Bonasio from the University of Pennsylvania will be honoured for his outstanding research in the field of epigenetics with the Max Planck-Humboldt Research Award, which is…

15/10/2020

DKTK School of Oncology fellows in Munich receive funding for translational research

In September 2020, the DKTK partner site München issued an internal call for proposals with the aim of selecting and funding translational oncological research projects proposed by early-career…

13/10/2020

Scientific DKTK Retreat 2020

Dieses Jahr müssen Veranstaltungen aufgrund der COVID-19-Pandemie umgeplant werden. Dies galt auch für den Wissenschaftlichen DKTK-Retreat am 5. Oktober 2020, welcher dieses Jahr in einem virtuellen…

15/09/2020

ERC Starting Grant to junior scientist

The European Research Council (ERC) grants are considered a particularly honorable distinction for scientists at all career levels. With its "Starting Grants", the ERC aims to pave the way for…

27/07/2020

HARPOON: First DKTK Workshop on Harmonization of Molecular Tumor Boards

HARPOON (HArmonization of Reporting in PrecisiOn Oncology), the first DKTK workshop on harmonization of molecular tumor boards, took place on July 9 and 10. More than 130 physicians and scientists…

21/07/2020

7th Munich Cancer Retreat Goes Virtual

Cancel or postpone? This decision had to be made for almost all planned events in 2020 so far to avoid health risks for potential participants due to COVID19. To cancel was not an option, so the 7th…

15/06/2020

Promising laboratory research: radioresistant cancer cells can be attacked immunotherapeutically with UniCAR T cells

cientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the National Center for Tumor Diseases Dresden (NCT/UCC), together with an international team of researchers, have succeeded in…

04/06/2020

"Explosion in cancer genome": much more common than expected

Chromothripsis is a form of genome instability by which one or a few chromosomes virtually "explode(s)" in a presumably single catastrophic event. According to current opinion, chromothripsis occurs…

04/05/2020

Using mini colons to detect functional differences and weaknesses of colorectal cancer

One of the main features of colorectal cancer is that there are considerable differences between the tumors of individual patients - at genetic level and hence in terms of the response to treatment…

23/04/2020

Corona Pandemic: Leading European cancer centers share knowledge and experience in the care of cancer patients

Cancer patients are particularly at risk for infections because of their disease and its treatment. Due to the rapid spread of the coronavirus in Europe, cancer centers within a short period were…

16/04/2020

Gemeinsames DKTK-Patientenregister

DKTK scientists from all DKTK partner sites are establishing a common clinical data platform to collect information from tumor patients suffering from COVID-19 or patients, who have been tested for…

02/04/2020

Brain tumors in children: Hereditary genetic defect destabilizes protein regulation

The causes of 40 percent of all cases of certain medulloblastoma – dangerous brain tumors affecting children – are hereditary. These are the findings of a recent genetic analysis carried out by…

24/03/2020

DKFZ researchers in the fight against the COVID-19 pandemic

Scientists at the German Cancer Research Center (DKFZ) are playing an active part in the battle against the COVID-19 pandemic and have set up a task force called fightCOVID@DKFZ. In collaboration with…

03/03/2020

A new approach in leukemia research: Glucose deprivation stops malignant transformation of blood cells

Leukemia is caused by uncontrolled proliferation of immature blood cells. Cell growth requires a lot of energy, which comes primarily from glycolysis. In a research project funded by the Wilhelm…

25/02/2020

The most comprehensive map to date of the cancer genome published

The great hope of precision oncology is to be able to recommend effective drugs to cancer patients based on an analysis of their tumor genome. Recommendations like these must draw on careful…

24/02/2020

German Cancer Prize awarded to Andreas Trumpp

Identifying cancer stem cells in different types of cancer, finding their weak points, and using these results to counter the spread of tumors and curb their resistance to treatment are the goals DKTK…